Bloomberg reported on Tue (14 May) that Bayer AG was ordered to pay more than US$2 billion in damages to a Californian couple that claimed they got cancer as a result of using its Roundup weedkiller for about three decades.

The jury agreed that Alva and Alberta Pilliod’s exposure to Roundup used for residential landscaping was a “substantial factor” in their non-Hodgkin’s lymphoma. In addition to US$1 billion for each spouse, the jury awarded damages of about US$55 million for the couple’s medical bills and pain and suffering. After the verdict, the couple’s lawyer said the evidence showed that “from day one, Monsanto (Bayer’s subsidiary) has never had any interest in finding out whether Roundup is safe.”

This is the 3rd trial Bayer has lost over the Roundup debacle. It’s also the largest jury award in the U.S. so far this year.

Bayer lost the first trial in Aug last year when a California state court ruled that Roundup caused the terminal cancer of Dewayne Johnson, a former school groundskeeper. In Mr Johnson’s case, the jury found Monsanto had “acted with malice or oppression” and awarded him US$289 million in damages. The damages were later reduced to US$78 million.

It lost the 2nd trial in March at a federal court, which ruled that Roundup was responsible for a Mr Hardeman’s cancer. During the trial, the 70-year-old testified that he had use the weed killer for a long period of time and at one time got it on his skin before he was diagnosed with cancer. The jury decided to award US$80 million to the victim and was perturbed that the company did not warn the plaintiff of the herbicide’s alleged cancer risks.

Roundup was produced by Bayer’s subsidiary Monsanto. In fact, it was Singapore’s Temasek Holdings which helped Bayer acquire Monsanto. It was reported in Apr last year that Bayer sold 3.6 per cent stake to Temasek for 3 billion euros at 96.77 euros per share. The money was used as part of Bayer’s plan to takeover Monsanto.

Together with its existing holding in Bayer, Temasek would then own about 4 percent in Bayer after the transaction. By Jun last year, with Temasek’s help, Bayer successfully acquired Monsanto to become the biggest seed and agricultural chemical maker in the world.

Bayer’s share price sinking

Not surprisingly, Bayer share price dropped. It has been steadily sinking since the first adverse verdict in the Roundup lawsuit was announced last August. As of yesterday (15 May), Bayer’s share price closed at 56.45 euros. Since Temasek bought 3 billion euros worth of shares at 96.77 euros in Apr last year, that means it has lost 40.32 euros per share or 41.7% of the 3 billion euros investment.

Analysts at Bloomberg Intelligence raised their estimate for a potential settlement value to as much as $10 billion, up from a peak of $6 billion.

“The company has got to come to the table with a viable plan to resolve these cases, or the losses are going to mount,” Micah Dortch, managing partner at the Potts Law Firm in Dallas who has filed dozens of Roundup cases, said. “This outcome should make Monsanto realize the seriousness of these claims and how a jury perceives the evidence.”

During the 3rd trial, when the company’s lawyer asked a juror after the verdict what the panel wanted to hear from Bayer, the juror responded that he wanted proof the chemical was safe: “I wanted you to get up and drink it.”

There are now more than 13,400 people want to sue Bayer and its subsidiary Monsanto.

“The verdict in this trial has no impact on future cases and trials, as each one has its own factual and legal circumstances,” Bayer said. It continues to defend the safety of Roundup’s active ingredient glyphosate since inheriting the product from Monsanto.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

Female cyclist fatally injured in accident along Pioneer Road North after bus driver loses control of vehicle

A 47-year-old woman who was cycling along Pioneer Road North (near Nanyang…

Wheel of fortune?

Officials in Singapore have changed the direction of the world’s biggest observation…

被断保 截肢老人上诉成功后离世 林瑞莲:“严重伤残”标准何在?

工人党主席林瑞莲,在国会辩论终身护保议题时,揭露一名符合资格的截肢老人,乐龄健保赔付中途被终止,辗转上诉成功后成功续保。可惜这名老人无法继续享有这份福利,在续保不到一月,就与世长辞。 林瑞莲分享,不久前她的选民K先生去世,生前饱受后期肾衰竭折磨,也因糖尿病截肢。然而保险单位以K先生仍有“部分”能力自理六项起居活动,取消了他的乐龄健保赔付。 “K先生后来被转移到临终关怀,保险机构要求他,要重新索赔,仍要填表格上诉。K先生曾在临终关怀中心托我协助,惟他女儿后来填了表格,在医生协助下,让K先生重新领取乐龄健保赔付。可惜不到一个月后,他离开了人世。” 林瑞莲对于如何衡量“伤残”的标准,来决定保户是否符合健保索偿资格感到困惑,特别是政府收了上亿元的保费,但是K先生这样的个案却无法享有保障,如果相同情况也发生在即将落实的终身护保,令人难以接受。 无法自理其中一项,生活就已够困难 方荣發议员也声援林瑞莲,呼吁检讨“严重伤残”定义,特别是降低门槛,让无法自理两项生活起居的保户,也能索赔。 “不要说六项,障友无法自理其中一项,生活都已经面对很大挑战。2018年检讨乐龄健保,倡议扩大保障范围,制定更具包容性的重度伤残定义,岂非合情合理?“ 根据“独立新闻网”报导,K先生的兄弟在社交媒体留言,他们来自低收入家庭,其兄嫂为了哥哥拜访了很多单位,但都以不符合资格为由,拒绝了K先生的援助申请。 乐龄健保计划,已收取33亿元保费,但是只有1亿3千300万元被索偿。至于终身护保将在2020年落实,凡是30岁以上公民都强制性参与,一直付保费到67岁。

An impassioned plea from a senior Singaporean

TOC reader Patriot calls for conscience and understanding from the govt.